{"disease":{"id":"primary-brain-neoplasms","name":"primary brain neoplasms"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06118723","title":"The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)","phase":"","overall_status":"RECRUITING","enrollment_count":784,"lead_sponsor_name":"Jasper Gerritsen","has_results":false},{"nct_id":"NCT03423628","title":"A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":180,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT07426848","title":"OT SMILE: Occupational Therapy Group Intervention for Primary Brain Tumour Patients","phase":"NA","overall_status":"RECRUITING","enrollment_count":96,"lead_sponsor_name":"Royal College of Surgeons, Ireland","has_results":false},{"nct_id":"NCT04543188","title":"A FIH Study of PF-07284890 in Participants With BRAF V600 Mutant Solid Tumors With and Without Brain Involvement","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":65,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT01505569","title":"Auto Transplant for High Risk or Relapsed Solid or CNS Tumors","phase":"NA","overall_status":"COMPLETED","enrollment_count":44,"lead_sponsor_name":"Masonic Cancer Center, University of Minnesota","has_results":false},{"nct_id":"NCT02193347","title":"IDH1 Peptide Vaccine for Recurrent Grade II Glioma","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Katy Peters, MD, PhD","has_results":true},{"nct_id":"NCT02692898","title":"Biomarker Analysis of Central Nervous System Tumors","phase":"","overall_status":"TERMINATED","enrollment_count":12,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false}],"total":7},"guidelines":[],"source":"Drug Landscape verified database"}